¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bacterial cell protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • globoid cell leukodystrophy
    °ø¼¼Æ÷¹é»öÁúÀå¾Ö, ±¸Çü¼¼Æ÷¹éÁúµð½ºÆ®·ÎÇÇ
  • glomus cell
    Å丮¼¼Æ÷
  • goblet cell
    ¼úÀܼ¼Æ÷
  • Golgi cell
    °ñÁö¼¼Æ÷
  • gonadotrope cell
    »ý½Ä»ùÀڱؼ¼Æ÷, »ý½Ä¼±Àڱؼ¼Æ÷
  • ganglion cell
    ½Å°æÀý¼¼Æ÷
  • ganglion cell layer
    ½Å°æÀý¼¼Æ÷Ãþ
  • granular cell myoblastoma
    °ú¸³¼¼Æ÷±Ù(À°)¸ð¼¼Æ÷Á¾
  • granular cell tumor
    °ú¸³¼¼Æ÷Á¾¾ç
  • granule cell
    °ú¸³¼¼Æ÷
  • granulosa cell
    °ú¸³Ãþ¼¼Æ÷
  • granulosa cell carcinoma
    °ú¸³¼¼Æ÷¾ÏÁ¾
  • granulosa cell tumor
    °ú¸³¸·¼¼Æ÷Á¾¾ç
  • granulosa-theca cell tumor
    °ú¸³³­Æ÷¸·¼¼Æ÷Á¾¾ç
  • hypersensitized cell
    °ú¹Î°¨¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • inflammatory cell
    ¿°Áõ¼¼Æ÷
  • infundibular cell
    ±ò¶§±â¼¼Æ÷
  • intercalated cell
    »çÀ̼¼Æ÷, °³Àç¼¼Æ÷
  • interdental cell
    û°¢Ä¡¾Æ»çÀ̼¼Æ÷, Ä¡°£¼¼Æ÷
  • interstitial cell
    »çÀÌÁú¼¼Æ÷
  • islet cell
    ¼¶¼¼Æ÷
  • islet cell carcinoma
    ¼¶¼¼Æ÷¾ÏÁ¾
  • juvenile cell
    À¯¾à¼¼Æ÷
  • killer cell
    ¼¼Æ÷µ¶¼º¼¼Æ÷
  • Kupffer¡¯s cell
    º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
  • lacunar cell
    °ø°£¼¼Æ÷
  • large cell carcinoma
    Å«¼¼Æ÷¾ÏÁ¾, ´ë¼¼Æ÷¾ÏÁ¾
  • lepra cell
    ³ªº´¼¼Æ÷
  • leukemic cell
    ¹éÇ÷º´¼¼Æ÷
  • light cell
    ¹àÀº¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • giant cell fibroblastoma
    °Å´ë¼¼Æ÷ ¼¶À¯¸ð¼¼Æ÷Á¾
  • giant cell glioma
    °Å¼¼Æ÷±³Á¾.
  • giant cell granuloma
    °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • giant cell granuloma,reparative
    ¼öº¹¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • giant cell histiocytoma
    °Å´ë¼¼Æ÷ Á¶Á÷±¸Á¾
  • giant cell leukemia
    °Å¼¼Æ÷¹éÇ÷º´.
  • giant cell myeloma
    °Å¼¼Æ÷°ñ¼öÁ¾.
  • giant cell myocarditis
    °Å´ë¼¼Æ÷¼º ½É±Ù¿°(¡­ãýÐÉæú)
  • giant cell pneumonia
    °Å¼¼Æ÷Æó·Å.
  • giant cell tumor
    °Å¼¼Æ÷Á¾¾ç.
  • giant cell tumor
    °Å´ë¼¼Æ÷Á¾¾ç.(¡­ðþåË)
  • giant cell, langhans
    ¶ûÇѽº °Å´ë¼¼Æ÷, Langhans °Å´ë¼¼Æ÷
  • giant pyramidal cell
    Å«ÇǶó¹Ô½Å°æ¿ø, °Å´ëÃßü¼¼Æ÷(¡­õÐô÷á¬øà).
  • gingiva,giant cell granuloma of
    °Å´ë¼¼Æ÷ À°¾ÆÁ¾
  • glandular cell
    »ù¼¼Æ÷, ¼±¼¼Æ÷(àÍá¬øà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • protein-losing
    ´Ü¹é»ó½Ç¼º.
  • protein-losing enteropathy
    ´Ü¹é»ó½Ç¼º À庴Áõ(íóÜ»ñø)
  • protein-losing enteropathy
    ´Ü¹é»ó½ÇÀ庴Áõ(Ó±ÛÜßÃã÷íóÜ»ñø)
  • purified protein derivative
    Á¤Á¦´Ü¹éÁúÀ¯µµÃ¼.
  • racemized protein
    ¶ó¼¼¹ÌÈ­´Ü¹éÁú(¡­ûùÓ±ÛÜòõ).
  • ras protein
    ras ´Ü¹é(¡­Ó±ÛÜ)
  • reserve protein
    ÀúÀå´Ü¹éÁú.
  • retinol-binding protein
    ·¹Æ¼³î°áÇմܹé(Áú)(·¹Æ¼³î Ì¿ùêÓ±ÛÜòõ)
  • serum protein
    Ç÷û´Ü¹é
  • serum protein
    Ç÷û´Ü¹éÁú(¡­Ó±ÛÜòõ).
  • serum protein bound iodine
    Ç÷û´Ü¹é°áÇÕ ¿äµå.
  • specific protein
    ƯÀ̴ܹéÁú(÷åì¶Ó±ÛÜòõ).
  • sphingolipid activator protein I deficiency
  • spindle protein
    ¹æÃßü´Ü¹éÁú(¡­ô÷Ó±ÛÜòõ).
  • stable plasma protein solution =SPPS
    ¾ÈÁ¤Ç÷Àå(´Ü¹é)¿ë¾×(¡­úìíìÓ±ÛÜéÁ äû).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • protein coat
    ´Ü¹éÁú(Ó±ÛÜòõ) ÄÚÆ®
  • protein conformation
    ´Ü¹éÁú(Ó±ÛÜòõ) ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • protein domain
    ´Ü¹éÁú ¿µ¿ª(Ó±ÛÜòõÖÅæ´)
  • protein efficiency ratio
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ(üù×ËÝï)
  • protein efficiency ratio method
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ¹ý(üù×ËÝïÛö)
  • protein engineering
    ´Ü¹éÁú °ø¹ý(Ó±ÛÜòõÍïÛö)
  • protein error
    ´Ü¹éÁú ¿ÀÂ÷(Ó±ÛÜòõè¦ó¬)
  • protein evolution
    ´Ü¹éÁú ÁøÈ­(Ó±ÛÜòõòäûù)
  • protein export
    ´Ü¹éÁú À¯Ãâ(Ó±ÛÜòõ×µõó)
  • protein factor
    ´Ü¹éÁú ÀÎÀÚ(Ó±ÛÜòõì×í­)
  • protein folding
    ´Ü¹éÁú(Ó±ÛÜòõ) Á¢±â
  • protein fractionation
    ´Ü¹éÁú ºÐȹȭ(Ó±ÛÜòõÝÂüñûù)
  • protein free filtrate
    Á¦(ð¶)´Ü¹éÁú ¿©°ú¾×(Ó±ÛÜòõÕëΦäû)
  • protein import
    ´Ü¹éÁú À¯ÀÔ(Ó±ÛÜòõ×µìý)
  • protein index
    ´Ü¹éÁú ÁöÇ¥(Ó±ÛÜòõò¦øö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
IBP insulin-like growth factor binding protein; International Biological Program; intra-aortic balloon p...
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
LSP left sacroposterior [fetal position]; linguistic string project; liver-specific protein; lymphocyte-...
MIP macrophage inflammatory protein; major intrinsic protein; maximum inspiratory pressure; maximum inte...
MTP maximum tolerated pressure; medial tibial plateau; median time to progression; metacarpophalangeal; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
BCDF B cell differentiation factor
BCGF II B cell growth factor II
BCL1 B cell leukemia
BLPD B cell lympho-proliferative disorders
BCL B cell lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lamina IV cell
    Á¦4Ãþ ¼¼Æ÷
    1. µÕ±Û°í »ï°¢Çü ȤÀº º° ¸ð¾çÀÇ ½Å°æ ¼¼Æ÷°¡ ³ôÀº ¹Ðµµ·Î ¹è¿­µÇ¾î ÀÖ´Ù. 2. °¡º­¿î Á¢ÃË °°Àº ³·Àº ¿ªÄ¡ÀÇ Àڱؿ¡ ¹ÝÀÀÇÑ´Ù.
  • laminar I cell
    Á¦ 1Ãþ ¼¼Æ÷
    1. ÀÛ°í Áß°£ Å©±âÀÇ ¼¼Æ÷¿Í ºÐ»êµÇ¾î ÀÖ´Â Å« ¹æÃßÇüÀÇ ¼¼Æ÷µé·Î ±¸¼ºµÈ´Ù. 2. Èİ¢ÀÇ º¼·ÏÇÑ Ç¥¸é¿¡ ÆòÇàÇÏ°Ô ¹è¿­µÇ¾î ÀÖ´Ù. 3. ¿£ÄÉÆÈ¸°, ½áºê½ºÅº½º P¸¦ ÇÔÀ¯Çϰí ÀÖ´Ù.
  • laminar II cell
    Á¦ 2Ãþ ¼¼Æ÷
  • laminar ¥± cell
    Á¦ 2Ãþ ¼¼Æ÷
    Á¦ 2ÃþÀÇ ¼¼Æ÷´Â 2Á¾·ù°¡ Àִµ¥ ÃþÀÇ ¹Ù±ù ÂÊ 1/4´Â ´õ¿í ÀÛÀº ¼¼Æ÷·Î ÅëÁõ°ú ¿­¿¡ ´ëÇÑ ¼ö¿ëü¸¦ °¡Áö°í ÀÖ°í, ¾È ÂÊ 3/4´Â Á» ´õ Å« ¼¼Æ÷·Î ¹«µ¶¼ºÀÇ ±â°è¼ö¿ëü¸¦ °¡Áö°í ÀÖ´Ù.
  • Langerhans cell
    ¶û°Ô¸£Çѽº ¼¼Æ÷, Ç¥ÇÇ¼Ó Å« Æ÷½Ä¼¼Æ÷
    µ¿ÀǾî=intrae
  • large cell
    ´ë¼¼Æ÷
    ƯÁ¤ ÀÌÀ¯°¡ ÀÖ¾î
  • LE cell
    LE ¼¼Æ÷, È«¹Ý¼º ³¶Ã¢ ¼¼Æ÷
    µÕ±Û°í, ±ÕÁú·Î º¸ÀÌ´Â ºÀÀÔü¸¦ ޽ÄÇÑ ¼º¼÷ È£Áß±¸¼º ´ÙÇÙ ¹éÇ÷±¸. ±× ºÀÀÔü ÀÚü´Â ´Ù¸¥ È£Áß±¸¿¡¼­ À¯·¡µÈ °ÍÀÌ´Ù. È«¹Ý¼º ·çǪ½º¿¡ ƯÀ¯ÇÑ °ÍÀÌÁö¸¸ °áÇÕ Á¶Á÷ÀÇ À¯»çÇÑ Áúȯ¿¡¼­µµ °üÂûµÈ´Ù.
  • lingual benign giant cell tumor
    ¾ç¼º °Å´ë ¼¼Æ÷ ¼³ Á¾¾ç
  • lupus erythematosus cell
    È«¹Ý¼º ·çǪ½º ¼¼Æ÷, È«¹Ý¼º ³¶Ã¢ ¼¼Æ÷
  • M-cell
    M ¼¼Æ÷
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
  • mast cell
    ºñ¸¸ ¼¼Æ÷
    µ¿¹°ÀÇ °áÇÕ Á¶Á÷ ¼Ó¿¡ ÀÖ´Â ¼¼Æ÷·Î ¸¸¼º ¿°Áõ¿¡ À־ÀÇ Áõ½Ä Á¶Á÷ ¼Ó¿¡ ¸¹¾Æ¼­ ÀÌ·± À̸§ÀÌ ºÙ¾ú´Ù. ÀÌ ¼¼Æ÷ ¼Ó¿¡´Â ¸¹Àº °ú¸³ÀÌ µé¾îÀÖ¾î ¿°Áõ ¹ÝÀÀ¿¡ °ü¿©Çϰí ÀÖ´Ù.
  • mature daughter cell
    ¼º¼÷ÇÑ µþ ¼¼Æ÷
  • mean cell

    mean cell hemoglobin (Æò±Õ ÀûÇ÷±¸ Ç÷»ö¼Ò

  • mean cell volume
    Æò±Õ ÀûÇ÷±¸ ¿ëÀû
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
myelin proteolipid protein A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed.
(12 Dec 1998)
myeloblastic protein See: human leukaemia-associated antigens.
(05 Mar 2000)
myeloma protein <haematology, oncology> The immunoglobulins and Bence Jones proteins secreted by myeloma cells.
(18 Nov 1997)
myod protein A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, myod appears to be related to fusion and terminal differentiation of the muscle cell.
(12 Dec 1998)
C protein <cell biology> Striated muscle thick filament associated proteins (140-150 kD) that show up in the C zone of the A band as 43nm transverse stripes. Structurally related to various other myosin binding proteins (twitchin, titin, myosin light chain kinase, skelemin, 86 kD protein, projectin, M protein).
(18 Nov 1997)
myotonin-protein kinase <enzyme> Has been sequenced
Registry number: EC 2.7.-
Synonym: mtpk, myotonin protein kinase
(26 Jun 1999)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
CRK4 protein kinase <enzyme> From mouse, has 85% amino acid identity with xenopus m015 protein kinase; genbank x74145
Registry number: EC 2.7.10.-
Synonym: crk4 pk
(26 Jun 1999)
H1-related protein-tyrosine phosphatase <enzyme> Has tyrosine and threonine/serine phosphatase activities
Registry number: EC 3.1.3.-
Synonym: vaccinia virus h1-related protein tyrosine phosphatase, vhr ptpase, vh-ptp13
(26 Jun 1999)
cro protein <protein> Protein synthesised by bacteriophage lambda in the lytic state. The cro protein blocks the synthesis of the lambda repressor (that is produced in the lysogenic stage and inhibits cro protein synthesis). Production of the cro protein in turn controls a set of genes associated with rapid virus multiplication.
(18 Nov 1997)
haemagglutinin-neuraminidase protein <protein> A protein found in the capsid of the Sendai virus which is exceptionally good at binding to the cytoplasmic membranes of many animal cells. The protein is therefore used to make fusogenic vesicles for the purpose of delivering therapeutic drugs or other chemicals directly into cells.
(09 Oct 1997)
crude protein Incomplete proteins which lack essential amino acids.
(09 Oct 1997)
crystalline protein <protein> The major protein found in the lens of the vertebrate eye, it can be dissolved in water easily.
(09 Oct 1997)
Csk-like protein-tyrosine kinase <enzyme> Phosphorylates c-terminal conserved tyr of src family members; from mouse brain; has 52% identity with mouse csk; mw 52 kD; genbank u05210
Registry number: EC 2.7.1.-
Synonym: ctk (kinase), ctk gene product, csk-type protein-tyrosine kinase, ntk (kinase), bhk (kinase)
(26 Jun 1999)
C-terminal leucine protein methyltransferase <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues
Registry number: EC 2.1.1.-
Synonym: tlp methyltransferase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á